Antibodies
24 April 2008
ESBATech’s Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications24 April 2008
MorphoSys and the Leibniz-Institut für Molekulare Pharmakologie Sign Broad Research Partnership24 April 2008
Arana and Kyowa Hakko to co-develop anti-cancer drug23 April 2008
ImClone Announces Agreement with FDA on Special Protocol Assessment for Phase III Study of IMC-1121B in Breast Cancer22 April 2008
Human Genome Sciences completes enrollment in first of two phase 3 LYMPHOSTAT-B(R) trials21 April 2008
Trubion Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Rheumatoid Arthritis16 April 2008
Medarex Reports Phase 1/2 Clinical Data of MDX-060 in Lymphoma at American Association for Cancer Research Meeting16 April 2008
Human Genome Sciences Advances Oncology Portfolio15 April 2008
Seattle Genetics Presents Preclinical Data on its Antibody-Drug Conjugate Technology and SGN-33 Program at AACRNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports